Drug recall
Red Blood Cells, Leukocytes Reduced
FDA recall event 84873 · Class III · American Natl. Red Cross-Greater Chesapeake & Potomac Region
Key facts
| Event ID | 84873 |
|---|---|
| Recall numbers | B-0298-2020 |
| Recalling firm | American Natl. Red Cross-Greater Chesapeake & Potomac Region |
| Product type | Biologics |
| Products | Red Blood Cells, Leukocytes Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Misbranded Red Blood Cells, Leukocytes Reduced, were distributed. |
| Initiation date | Jan 10, 2020 |
| Report date | Feb 26, 2020 |
| Termination date | Feb 19, 2020 |
| City | Baltimore |
| State | MD |
| Country | United States |
| FEI number | 1173011 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: